251 related articles for article (PubMed ID: 35254390)
1. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
Dolui S; Detre JA; Gaussoin SA; Herrick JS; Wang DJJ; Tamura MK; Cho ME; Haley WE; Launer LJ; Punzi HA; Rastogi A; Still CH; Weiner DE; Wright JT; Williamson JD; Wright CB; Bryan RN; Bress AP; Pajewski NM; Nasrallah IM
JAMA Neurol; 2022 Apr; 79(4):380-389. PubMed ID: 35254390
[TBL] [Abstract][Full Text] [Related]
2. Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial.
Nasrallah IM; Gaussoin SA; Pomponio R; Dolui S; Erus G; Wright CB; Launer LJ; Detre JA; Wolk DA; Davatzikos C; Williamson JD; Pajewski NM; Bryan RN;
JAMA Neurol; 2021 May; 78(5):568-577. PubMed ID: 33683313
[TBL] [Abstract][Full Text] [Related]
3. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.
; Nasrallah IM; Pajewski NM; Auchus AP; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Doshi J; Erus G; Fine LJ; Gaussoin SA; Harris D; Johnson KC; Kimmel PL; Kurella Tamura M; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB; Williamson JD; Bryan RN
JAMA; 2019 Aug; 322(6):524-534. PubMed ID: 31408137
[TBL] [Abstract][Full Text] [Related]
4. Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
Rashid T; Li K; Toledo JB; Nasrallah I; Pajewski NM; Dolui S; Detre J; Wolk DA; Liu H; Heckbert SR; Bryan RN; Williamson J; Davatzikos C; Seshadri S; Launer LJ; Habes M
JAMA Netw Open; 2023 Mar; 6(3):e231055. PubMed ID: 36857053
[TBL] [Abstract][Full Text] [Related]
5. Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure.
Kurella Tamura M; Gaussoin S; Pajewski NM; Zaharchuk G; Freedman BI; Rapp SR; Auchus AP; Haley WE; Oparil S; Kendrick J; Roumie CL; Beddhu S; Cheung AK; Williamson JD; Detre JA; Dolui S; Bryan RN; Nasrallah IM;
Am J Kidney Dis; 2022 May; 79(5):677-687.e1. PubMed ID: 34543687
[TBL] [Abstract][Full Text] [Related]
6. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial.
Ghazi L; Shen J; Ying J; Derington CG; Cohen JB; Marcum ZA; Herrick JS; King JB; Cheung AK; Williamson JD; Pajewski NM; Bryan N; Supiano M; Sonnen J; Weintraub WS; Greene TH; Bress AP
JAMA Netw Open; 2023 May; 6(5):e2314443. PubMed ID: 37204788
[TBL] [Abstract][Full Text] [Related]
7. Blood Pressure Variability and Cerebral Perfusion Decline: A Post Hoc Analysis of the SPRINT MIND Trial.
Sible IJ; Nation DA
J Am Heart Assoc; 2023 Jun; 12(12):e029797. PubMed ID: 37301768
[TBL] [Abstract][Full Text] [Related]
8. Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial.
Croall ID; Tozer DJ; Moynihan B; Khan U; O'Brien JT; Morris RG; Cambridge VC; Barrick TR; Blamire AM; Ford GA; Markus HS;
JAMA Neurol; 2018 Jun; 75(6):720-727. PubMed ID: 29507944
[TBL] [Abstract][Full Text] [Related]
9. Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial.
Rapp SR; Gaussoin SA; Sachs BC; Chelune G; Supiano MA; Lerner AJ; Wadley VG; Wilson VM; Fine LJ; Whittle JC; Auchus AP; Beddhu S; Berlowitz DR; Bress AP; Johnson KC; Krousel-Wood M; Martindale-Adams J; Miller EC; Rifkin DE; Snyder JK; Tamariz L; Wolfgram DF; Cleveland ML; Yang M; Nichols LO; Bryan RN; Reboussin DM; Williamson JD; Pajewski NM;
Lancet Neurol; 2020 Nov; 19(11):899-907. PubMed ID: 33098800
[TBL] [Abstract][Full Text] [Related]
10. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Vaduganathan M; Claggett BL; Juraschek SP; Solomon SD
JAMA Cardiol; 2020 May; 5(5):576-581. PubMed ID: 32101262
[TBL] [Abstract][Full Text] [Related]
12. Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial.
Jaeger BC; Bress AP; Bundy JD; Cheung AK; Cushman WC; Drawz PE; Johnson KC; Lewis CE; Oparil S; Rocco MV; Rapp SR; Supiano MA; Whelton PK; Williamson JD; Wright JT; Reboussin DM; Pajewski NM
JAMA Cardiol; 2022 Nov; 7(11):1138-1146. PubMed ID: 36223105
[TBL] [Abstract][Full Text] [Related]
13. Intensive systolic blood pressure treatment remodels brain perivascular spaces: A secondary analysis of the Systolic Pressure Intervention Trial (SPRINT).
Kern KC; Nasrallah IM; Bryan RN; Reboussin DM; Wright CB
Neuroimage Clin; 2023; 40():103513. PubMed ID: 37774646
[TBL] [Abstract][Full Text] [Related]
14. Intensive blood pressure lowering increases cerebral blood flow in older subjects with hypertension.
Tryambake D; He J; Firbank MJ; O'Brien JT; Blamire AM; Ford GA
Hypertension; 2013 Jun; 61(6):1309-15. PubMed ID: 23529166
[TBL] [Abstract][Full Text] [Related]
15. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.
Inoue K; Watson KE; Kondo N; Horwich T; Hsu W; Bui AAT; Duru OK
JAMA Netw Open; 2022 Mar; 5(3):e222037. PubMed ID: 35285922
[TBL] [Abstract][Full Text] [Related]
16. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering: Findings From the SPRINT Randomized Clinical Trial.
Berry JD; Nambi V; Ambrosius WT; Chen H; Killeen AA; Taylor A; Toto RD; Soliman EZ; McEvoy JW; Pandey A; Joshi PH; Blankenberg S; Kitzman DW; Ballantyne CM; de Lemos JA
JAMA Cardiol; 2021 Dec; 6(12):1397-1405. PubMed ID: 34468696
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial.
Zheutlin AR; Mondesir FL; Derington CG; King JB; Zhang C; Cohen JB; Berlowitz DR; Anstey DE; Cushman WC; Greene TH; Ogedegbe O; Bress AP
JAMA Netw Open; 2022 Jan; 5(1):e2143001. PubMed ID: 35006243
[TBL] [Abstract][Full Text] [Related]
18. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.
; Williamson JD; Pajewski NM; Auchus AP; Bryan RN; Chelune G; Cheung AK; Cleveland ML; Coker LH; Crowe MG; Cushman WC; Cutler JA; Davatzikos C; Desiderio L; Erus G; Fine LJ; Gaussoin SA; Harris D; Hsieh MK; Johnson KC; Kimmel PL; Tamura MK; Launer LJ; Lerner AJ; Lewis CE; Martindale-Adams J; Moy CS; Nasrallah IM; Nichols LO; Oparil S; Ogrocki PK; Rahman M; Rapp SR; Reboussin DM; Rocco MV; Sachs BC; Sink KM; Still CH; Supiano MA; Snyder JK; Wadley VG; Walker J; Weiner DE; Whelton PK; Wilson VM; Woolard N; Wright JT; Wright CB
JAMA; 2019 Feb; 321(6):553-561. PubMed ID: 30688979
[TBL] [Abstract][Full Text] [Related]
19. Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial.
Odden MC; Peralta CA; Berlowitz DR; Johnson KC; Whittle J; Kitzman DW; Beddhu S; Nord JW; Papademetriou V; Williamson JD; Pajewski NM;
JAMA Intern Med; 2017 Apr; 177(4):500-507. PubMed ID: 28166324
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
